John Capek - Abbott Laboratories Insider

ABTT34 -- Brazil Stock  

BRL 71.09  0.64  0.89%

Dr. John M. Capek, Ph.D. is Executive Vice President Ventures of the Company. Previously, he served as Senior Vice President, Abbott Vascular, heading up Abbott global vascular business. Dr. Capek served in various management roles at Guidant, including president, Guidant Vascular Intervention and Vice President and General Manager of Bioabsorbable Vascular Solutions. He also served as Vice President and General Manager of Guidant Germany and Vice President, Marketing, Guidant Cardiac Rhythm Management Group. Before joining Guidant, Dr. Capek was manager of New Product Technology at Eli Lilly Company
Age: 54  EVP Since 2015      
Capek has a Bachelor degree in Biomedical Engineering, a Master degree in Biomedical Engineering, a Master degree in Electrical Engineering, a Ph.D. in Biomedical Engineering and a Master degree in Business Administration from Rensselaer Polytechnic Institute.

John Capek Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 3.17 % which means that it generated profit of $3.17 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 2.63 % meaning that it generated $2.63 on every $100 dollars invested by stockholders.
The company has accumulated 20.9 B in total debt with debt to equity ratio (D/E) of 67.9 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Abbott Laboratories has Current Ratio of 1.55 which is within standard range for the sector.

Similar Executives

Found 3 records

EVP Since

Avid ModjtabaiWells Fargo Company
Timothy SloanWells Fargo Company
Carrie TolstedtWells Fargo Company

Entity Summary

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company was founded in 1888 and is headquartered in Abbott Park, Illinois. Abbott Laboratories operates under Medical Devices classification in Brazil and traded on Sao Paolo Stock Exchange. It employs 99000 people.Abbott Laboratories (ABTT34) is traded on Sao Paolo Stock Exchange in Brazil. It is located in 100 Abbott Park Road and employs 99,000 people.

Abbott Laboratories Leadership Team

Scott White, Senior Vice President - International Nutrition
Samuel Scott, Independent Director
Deepak Nath, Senior Vice President - Abbott Vascular
Jaime Contreras, Senior Vice President - Core Laboratory Diagnostics, Commercial Operations
Roger Bird, Senior Vice President - U.S. Nutrition
Nancy McKinstry, Independent Director
Heather Mason, Senior Vice President - Abbott Diabetes Care
James Farrell, Independent Director
Phebe Novakovic, Independent Director
JeanYves Pavee, Senior Vice President - Established Pharmaceuticals, Developed Markets
Andrew Lane, Senior Vice President - Established Pharmaceuticals, Emerging Markets
Roxanne Austin, Independent Director
Georges Vos, Senior Vice President - Established Pharmaceuticals, Emerging Markets
Stephen Fussell, Senior Vice President - Human Resources
Thomas Freyman, Executive VP of Fin. and Admin.
Sally Blount, Independent Director
Daniel Starks, Independent Director
Thomas Frinzi, Senior Vice President - Abbott Medical Optics
Eric Fain, Senior Vice President Group President - Cardiovascular and Neuromodulation
John Capek, Executive VP of Ventures
Robert Alpern, Independent Director
Murthy Simhambhatla, Senior Vice President - Abbott Medical Optics
Miles White, Chairman, CEO and Chairman of Executive Committee
Robert Ford, Senior Vice President Diabetes Care.
Glenn Tilton, Independent Director
Richard Ashley, Executive VP of Corporate Devel.
Michael Rousseau, President - Cardiovascular and Neuromodulation
Edward Liddy, Independent Director
Hubert Allen, Executive VP, General Counsel and Secretary
Charles Foltz, Senior Vice President - Abbott Vascular
Brian Yoor, CFO and Sr. VP of Fin.
John Stratton, Director
Joseph Manning, Senior Vice President - Abbott Nutrition International
Jared Watkin, Senior Vice President - Diabetes Care
William Osborn, Independent Director
Brian Blaser, Executive VP of Diagnostic Products
Michael Warmuth, Executive Vice President - Established Pharmaceuticals
Robert Funck, Vice President Controller
Daniel Salvadori, Senior Vice President Established Pharmaceuticals, Latin America.

Stock Performance Indicators

Did you try this?

Run Content Syndication Now


Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Content Syndication

Abbott Laboratories Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Abbott Laboratories and Apple. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .